Inovio Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Inovio Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 92% to $832,010. The net income raised on -$135,117,352 and profit margin reached -16240%. Total operating expenses were $132,555,129.
Profit Margin
| 2014 | 10.45M | -36.12M | -345.44% |
|---|---|---|---|
| 2015 | 40.57M | -29.18M | -71.94% |
| 2016 | 35.36M | -73.74M | -208.49% |
| 2017 | 42.22M | -88.20M | -208.92% |
| 2018 | 30.48M | -96.96M | -318.12% |
| 2019 | 4.11M | -120.55M | -2931.76% |
| 2020 | 7.41M | -215.08M | -2902.17% |
| 2021 | 1.77M | -305.38M | -17207.13% |
| 2022 | 10.26M | -287.66M | -2803.13% |
| 2023 | 832.01K | -135.11M | -16239.87% |
INO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 832.01K | 10.26M | 1.77M | 7.41M | 4.11M | 30.48M | 42.22M | 35.36M | 40.57M | 10.45M |
Cost of revenue | 3.50M | 5.49M | 4.73M | 94.24M | 88.01M | 0 | 0 | 0 | 0 | 0 |
Gross profit | -2.67M | 4.76M | -2.95M | -86.83M | -83.90M | 30.48M | 42.22M | 35.36M | 40.57M | 10.45M |
Operating exp. | ||||||||||
Research and development | 86.67M | 187.65M | 249.24M | 94.24M | 88.01M | 95.25M | 98.57M | 88.71M | 57.79M | 34.09M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 132.55M | 277.83M | 302.99M | 131.49M | 115.22M | 124.57M | 126.86M | 112.60M | 75.85M | 49.95M |
Operating income | -135.22M | -267.57M | -301.21M | -124.08M | -111.10M | -94.09M | -83.64M | -76.23M | -34.28M | -39.49M |
Other income (expenses), net | 109.30K | -10.07M | -2.00M | -38.80M | -9.70M | -1.62M | -4.56M | 2.23M | 3.08M | 3.35M |
Income before tax | -135.11M | -277.65M | -303.22M | -162.89M | -120.80M | -94.79M | -88.20M | -73.74M | -31.20M | -36.14M |
Income tax expense | 0 | 10.01M | 2.16M | 52.19M | -257.33K | 2.16M | 1.75M | -4.62M | -2.09M | -3.72M |
Net income | -135.11M | -287.66M | -305.38M | -215.08M | -120.55M | -96.96M | -88.20M | -73.74M | -29.18M | -36.12M |
Earnings per share | ||||||||||
Basic EPS | -6.09 | -14.47 | -17.55 | -16.64 | -14.65 | -1.05 | -1.08 | -1.01 | -0.43 | -0.61 |
Diluted EPS | -6.09 | -14.47 | -17.55 | -16.64 | -14.65 | -1.05 | -1.08 | -1.01 | -0.43 | -0.61 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |